Month: March 2013

FDA Approves Dotarem, a New MRI Agent

The U.S. Food and Drug Administration today approved Dotarem (gadoterate meglumine) for use in magnetic resonance imaging (MRI) of the brain, spine and associated tissues of patients ages 2 years and older. Dotarem is a...

Read More